Comparison of patients with hyperparathyroidism and normocalcaemic hyperparathyroidism with regard to bone metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022216

Enrollment

300

Registered

2021-03-31

Start date

2015-03-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M81.0 E21.0

Interventions

Group 1: Patients with primary hyperparathyroidism and normal serum calcium: Measurement of the parathyroid hormone level, Ca and Vit D in the blood and performance of an FDG PET to detect any storage

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elevated parathyroid hormone in primary hyperparathyroidism

Exclusion criteria

Exclusion criteria: Parathyroid hormone in the normal range (<65), secondary or tertiary hyperparathyroidism

Design outcomes

Primary

Measure	Time frame
Differences in bone metabolism concerning T scores and TBS between normo- and hypercalcemic patients with PHPT	—

Secondary

Measure	Time frame
Furthermore, differences in PET CT uptake in the patient groups will be investigated.	—

Countries

Austria

Contacts

Public ContactDagmar schaffler-schaden

Paracelsus Medizinische Privatuniversität Salzburg

dagmar.schaffler@pmu.ac.at+436643288078

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026